These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28026909)

  • 1. Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke.
    Gon Y; Sakaguchi M; Takasugi J; Kawano T; Kanki H; Watanabe A; Oyama N; Terasaki Y; Sasaki T; Mochizuki H
    Eur J Neurol; 2017 Mar; 24(3):503-508. PubMed ID: 28026909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of the number of territories involved on DWI-MRI to predict occult systemic malignancy in cryptogenic stroke patients.
    Guo L; Wang L; Liu W
    J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104823. PubMed ID: 32362555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of D-dimer levels for short-term or long-term outcomes in cryptogenic stroke patients.
    Nezu T; Kitano T; Kubo S; Uemura J; Yamashita S; Iwanaga T; Inoue T; Hosomi N; Maruyama H; Matsumoto M; Kimura K; Yagita Y
    J Neurol; 2018 Mar; 265(3):628-636. PubMed ID: 29372390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale.
    Kim YD; Song D; Nam HS; Lee K; Yoo J; Hong GR; Lee HS; Nam CM; Heo JH
    Thromb Haemost; 2015 Aug; 114(3):614-22. PubMed ID: 25994249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer.
    Nam KW; Kim CK; Kim TJ; An SJ; Demchuk AM; Kim Y; Jung S; Han MK; Ko SB; Yoon BW
    Eur J Neurol; 2017 Jan; 24(1):205-211. PubMed ID: 27766716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clues to occult cancer in patients with ischemic stroke.
    Kim SJ; Park JH; Lee MJ; Park YG; Ahn MJ; Bang OY
    PLoS One; 2012; 7(9):e44959. PubMed ID: 22984594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of cryptogenic stroke in cancer patients.
    Gon Y; Okazaki S; Terasaki Y; Sasaki T; Yoshimine T; Sakaguchi M; Mochizuki H
    Ann Clin Transl Neurol; 2016 Apr; 3(4):280-7. PubMed ID: 27081658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study.
    Guo YJ; Chang MH; Chen PL; Lee YS; Chang YC; Liao YC
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e249-54. PubMed ID: 24295603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voxel-Based Lesion Mapping of Cryptogenic Stroke in Patients with Advanced Cancer: A Detailed Magnetic Resonance Imaging Analysis of Distribution Pattern.
    Achiha T; Takagaki M; Oe H; Sakai M; Matsui H; Nakanishi K; Ozaki T; Fujimoto Y; Yoshimine T; Nakanishi K; Kinoshita M
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1521-1527. PubMed ID: 28363514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke.
    Alvarez-Perez FJ; Castelo-Branco M; Alvarez-Sabin J
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):986-92. PubMed ID: 21296900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-dimer and C-reactive Protein as Potential Biomarkers for Diagnosis of Trousseau's Syndrome in Patients with Cerebral Embolism.
    Tsushima M; Metoki N; Hagii J; Saito S; Shiroto H; Yasujima M; Kato T; Kudo N; Toyama Y; Yokono Y; Nozaka M; Kawamura Y; Nakata M; Tomita H
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104534. PubMed ID: 31810721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer and Body CT to Identify Occult Malignancy in Acute Ischemic Stroke.
    Rosenberg J; Do D; Cucchiara B; Messé SR
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105366. PubMed ID: 33039769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke.
    Nam KW; Kim CK; Kim TJ; An SJ; Oh K; Mo H; Kang MK; Han MK; Demchuk AM; Ko SB; Yoon BW
    PLoS One; 2017; 12(3):e0172793. PubMed ID: 28282388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-dimer levels and cerebral infarction in critically ill cancer patients.
    Ryu JA; Bang OY; Lee GH
    BMC Cancer; 2017 Aug; 17(1):591. PubMed ID: 28854911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study.
    Sánchez-López V; Marín-Romero S; Ferrer-Galván M; Elías-Hernández T; Lobo Beristain JL; Ballaz Quincoces A; Jara-Palomares L; Rodríguez Martorell FJ; Castro MJ; Marín Hinojosa C; López-Campos JL; Otero-Candelera R
    Am J Clin Pathol; 2024 May; 161(5):501-511. PubMed ID: 38340336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients.
    Wang JY; Zhang GJ; Zhuo SX; Wang K; Hu XP; Zhang H; Qu LD
    Neurol Res; 2018 Nov; 40(11):948-954. PubMed ID: 30317943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging value of serum D-dimer measurement in the work-up and management of ischemic stroke.
    Ohara T; Farhoudi M; Bang OY; Koga M; Demchuk AM
    Int J Stroke; 2020 Feb; 15(2):122-131. PubMed ID: 31537182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma D-dimer levels are associated with short-term poor outcome in patients with acute ischemic stroke: a prospective, observational study.
    Yao T; Tian BL; Li G; Cui Q; Wang CF; Zhang Q; Peng B; Gao Y; Zhan YQ; Hu D; Xu L; Wang GH
    BMC Neurol; 2019 Jul; 19(1):175. PubMed ID: 31331288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of survival for patients with cancer after cryptogenic stroke.
    Shin YW; Lee ST; Jung KH; Kim DY; Park CK; Kim TM; Choi SH; Chu K; Lee SK
    J Neurooncol; 2016 Jun; 128(2):277-84. PubMed ID: 26968716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism.
    Han D; ó Hartaigh B; Lee JH; Cho IJ; Shim CY; Chang HJ; Hong GR; Ha JW; Chung N
    PLoS One; 2016; 11(4):e0153514. PubMed ID: 27073982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.